A report indicates that approximately 14 million Medicare recipients could potentially obtain GLP-1 medications for approximately $50 per month. GLP-1 drugs are primarily used to manage type 2 diabetes and weight management. The expanded access could significantly reduce out-of-pocket costs for eligible beneficiaries who currently use or are considering these medications.
Weight & Metabolism · Jun 24, 2026 · 1 day ago
Medicare recipients may access GLP-1 medications at reduced cost
Read the full story at healthline.com →
This is a short summary written for HealthyFreePress; the full reporting belongs to the linked publisher, who receives the click and the credit. HealthyFreePress summarizes and links to health news — it is not a medical authority, and nothing here is medical advice. See our Medical Disclaimer and Editorial Policy.